Annual Total Expenses
$799.82 M
+$58.98 M+7.96%
December 31, 2023
Summary
- As of February 22, 2025, ACAD annual total expenses is $799.82 million, with the most recent change of +$58.98 million (+7.96%) on December 31, 2023.
- During the last 3 years, ACAD annual total expenses has risen by +$71.47 million (+9.81%).
- ACAD annual total expenses is now at all-time high.
Performance
ACAD Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$218.76 M
+$7.23 M+3.42%
September 30, 2024
Summary
- As of February 22, 2025, ACAD quarterly total expenses is $218.76 million, with the most recent change of +$7.23 million (+3.42%) on September 30, 2024.
- Over the past year, ACAD quarterly total expenses has dropped by -$50.72 million (-18.82%).
- ACAD quarterly total expenses is now -18.82% below its all-time high of $269.48 million, reached on September 30, 2023.
Performance
ACAD Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ACAD Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.0% | -18.8% |
| 3 y3 years | +9.8% | +48.9% |
| 5 y5 years | +69.7% | +56.3% |
ACAD Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +22.2% | -18.8% | +35.4% |
| 5 y | 5-year | at high | +36.6% | -18.8% | +48.9% |
| alltime | all time | at high | +5033.3% | -18.8% | +5195.9% |
ACADIA Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $218.76 M(+3.4%) |
| Jun 2024 | - | $211.53 M(+11.0%) |
| Mar 2024 | - | $190.62 M(-2.8%) |
| Dec 2023 | $799.82 M(+8.0%) | $196.10 M(-27.2%) |
| Sep 2023 | - | $269.48 M(+66.1%) |
| Jun 2023 | - | $162.20 M(-5.7%) |
| Mar 2023 | - | $172.05 M(-5.8%) |
| Dec 2022 | $740.83 M(+13.2%) | $182.55 M(+13.0%) |
| Sep 2022 | - | $161.58 M(-3.9%) |
| Jun 2022 | - | $168.21 M(-26.4%) |
| Mar 2022 | - | $228.48 M(+30.3%) |
| Dec 2021 | $654.58 M(-10.1%) | $175.41 M(+19.4%) |
| Sep 2021 | - | $146.91 M(-7.6%) |
| Jun 2021 | - | $158.93 M(-8.3%) |
| Mar 2021 | - | $173.33 M(-7.9%) |
| Dec 2020 | $728.34 M(+24.4%) | $188.17 M(-8.9%) |
| Sep 2020 | - | $206.48 M(+34.0%) |
| Jun 2020 | - | $154.11 M(-14.2%) |
| Mar 2020 | - | $179.58 M(+16.1%) |
| Dec 2019 | $585.62 M(+24.3%) | $154.72 M(+10.5%) |
| Sep 2019 | - | $140.01 M(-0.2%) |
| Jun 2019 | - | $140.30 M(-6.8%) |
| Mar 2019 | - | $150.59 M(+18.7%) |
| Dec 2018 | $471.25 M(+12.9%) | $126.85 M(+6.1%) |
| Sep 2018 | - | $119.58 M(-1.3%) |
| Jun 2018 | - | $121.14 M(+16.8%) |
| Mar 2018 | - | $103.69 M(-8.7%) |
| Dec 2017 | $417.31 M(+43.8%) | $113.57 M(+12.2%) |
| Sep 2017 | - | $101.22 M(+2.8%) |
| Jun 2017 | - | $98.51 M(-5.3%) |
| Mar 2017 | - | $104.01 M(+15.3%) |
| Dec 2016 | $290.15 M(+76.2%) | $90.19 M(+16.1%) |
| Sep 2016 | - | $77.67 M(+7.8%) |
| Jun 2016 | - | $72.02 M(+43.3%) |
| Mar 2016 | - | $50.27 M(+10.3%) |
| Dec 2015 | $164.67 M(+76.4%) | $45.58 M(+16.8%) |
| Sep 2015 | - | $39.04 M(-1.2%) |
| Jun 2015 | - | $39.50 M(-2.6%) |
| Mar 2015 | - | $40.56 M(+41.8%) |
| Dec 2014 | $93.35 M(+136.7%) | $28.60 M(+14.4%) |
| Sep 2014 | - | $25.01 M(+15.0%) |
| Jun 2014 | - | $21.75 M(+20.9%) |
| Mar 2014 | - | $17.99 M(+47.4%) |
| Dec 2013 | $39.44 M | $12.20 M(+10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $11.05 M(+15.0%) |
| Jun 2013 | - | $9.61 M(+46.0%) |
| Mar 2013 | - | $6.58 M(-8.6%) |
| Dec 2012 | $25.79 M(+3.5%) | $7.20 M(+22.3%) |
| Sep 2012 | - | $5.88 M(-2.4%) |
| Jun 2012 | - | $6.03 M(-9.8%) |
| Mar 2012 | - | $6.68 M(+13.2%) |
| Dec 2011 | $24.92 M(-7.8%) | $5.90 M(+4.0%) |
| Sep 2011 | - | $5.68 M(-19.4%) |
| Jun 2011 | - | $7.04 M(+11.9%) |
| Mar 2011 | - | $6.30 M(+0.3%) |
| Dec 2010 | $27.04 M(-47.9%) | $6.28 M(-4.1%) |
| Sep 2010 | - | $6.54 M(-0.8%) |
| Jun 2010 | - | $6.59 M(-13.6%) |
| Mar 2010 | - | $7.63 M(-27.2%) |
| Dec 2009 | $51.87 M(-24.4%) | $10.47 M(-6.5%) |
| Sep 2009 | - | $11.21 M(-23.4%) |
| Jun 2009 | - | $14.64 M(-5.8%) |
| Mar 2009 | - | $15.54 M(+6.9%) |
| Dec 2008 | $68.57 M(-2.3%) | $14.54 M(-11.2%) |
| Sep 2008 | - | $16.37 M(-14.8%) |
| Jun 2008 | - | $19.22 M(-0.1%) |
| Mar 2008 | - | $19.25 M(-5.1%) |
| Dec 2007 | $70.21 M(+22.8%) | $20.29 M(+2.2%) |
| Sep 2007 | - | $19.85 M(+35.4%) |
| Jun 2007 | - | $14.66 M(-4.9%) |
| Mar 2007 | - | $15.41 M(+0.6%) |
| Dec 2006 | $57.19 M(+22.3%) | $15.32 M(+5.8%) |
| Sep 2006 | - | $14.48 M(-1.8%) |
| Jun 2006 | - | $14.74 M(+16.7%) |
| Mar 2006 | - | $12.64 M(-3.8%) |
| Dec 2005 | $46.76 M(+52.3%) | $13.14 M(-20.3%) |
| Sep 2005 | - | $16.49 M(+83.0%) |
| Jun 2005 | - | $9.01 M(+10.9%) |
| Mar 2005 | - | $8.13 M(-4.8%) |
| Dec 2004 | $30.70 M(+45.4%) | $8.54 M(+8.0%) |
| Sep 2004 | - | $7.90 M(+14.5%) |
| Jun 2004 | - | $6.90 M(-6.2%) |
| Mar 2004 | - | $7.36 M(+70.1%) |
| Dec 2003 | $21.12 M(+11.7%) | - |
| Jun 2003 | - | $4.32 M(+4.7%) |
| Mar 2003 | - | $4.13 M |
| Dec 2002 | $18.90 M(-0.5%) | - |
| Dec 2001 | $18.99 M(+21.9%) | - |
| Dec 2000 | $15.58 M | - |
FAQ
- What is ACADIA Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual total expenses year-on-year change?
- What is ACADIA Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly total expenses year-on-year change?
What is ACADIA Pharmaceuticals annual total expenses?
The current annual total expenses of ACAD is $799.82 M
What is the all time high annual total expenses for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual total expenses is $799.82 M
What is ACADIA Pharmaceuticals annual total expenses year-on-year change?
Over the past year, ACAD annual total expenses has changed by +$58.98 M (+7.96%)
What is ACADIA Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of ACAD is $218.76 M
What is the all time high quarterly total expenses for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly total expenses is $269.48 M
What is ACADIA Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, ACAD quarterly total expenses has changed by -$50.72 M (-18.82%)